Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 37 out of 100. Tau biomarkers

Topic: Brain proteins, microglia and lab models

Plain-language summary

Abstract Background Astrocytic and microglial reactivity play a significant role in AD pathology, yet studies show conflicting results. Result Both taus are very significantly correlated ( p 0,697 in all groups), and with YKL‐40 (r>0.430). YKL‐40 is very significantly associated ( p <0.001) with GAP43 in Aβ+MCI and AD (r=0.428, r=0.460), and significantly so in Aβ‐MCI (r=0.308, p = 0.003). Additionally, YKL‐40 is very significantly associated ( p <0.001) with Aβ 1‐42 in Aβ‐MCI (r=0.442), and significantly so in Aβ+MCI and AD (r=0.181, p = 0.033; r=0.241, p = 0.023). 18F‐AV45_YKL‐40 voxel‐based regressions show a Braak‐like pattern, with more clusters in Aβ+MCI than Aβ‐MCI, and none in AD. A pro‐inflammatory Aβ‐tau‐associated response emerges first, and becomes mostly associated with tau in Aβ+MCI and AD.

What this study adds

Evidence grade: Low

The record lists 89 participants. This study examined associations between cerebrospinal fluid YKL-40 and Alzheimer's disease pathology markers, finding stage-specific relationships. It is a biomarker study and does not test or demonstrate any treatment, cure or prevention.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Tuil, M. E., Allehyany, B., & Edison, P. (2025). CSF YKL‐40 demonstrates stage‐specific effects of astrocytic reactivity on Alzheimer's Disease pathology. Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_100751

Vancouver

Tuil ME, Allehyany B, Edison P. CSF YKL‐40 demonstrates stage‐specific effects of astrocytic reactivity on Alzheimer's Disease pathology. Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_100751. PMID: 41447471.

BibTeX

@article{tuil2025-41447471,
  author  = {Tuil, Marie Emilie and Allehyany, Bshaier and Edison, Paul},
  title   = {{CSF YKL‐40 demonstrates stage‐specific effects of astrocytic reactivity on Alzheimer's Disease pathology}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_100751},
  pmid    = {41447471},
  url     = {https://doi.org/10.1002/alz70856_100751}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study examined associations between cerebrospinal fluid YKL-40 and Alzheimer's disease pathology markers, finding stage-specific relationships. It is a biomarker study and does not test or demonstrate any treatment, cure or prevention.

Study details

How this study scored 37/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 37 of 100.37 of 100 points earned63 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 89 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Paul Edison: h-index 53 (OpenAlex, whole career)
Institution's track record 2 / 3 Imperial College London: institution h-index 1,744 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41447471)
Free to read 2 / 2 Free to read
Total 37 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Tau biomarkers from nearby years

Also tagged “cerebrospinal”

820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Tau biomarkers

See all studies in Tau biomarkers →